Research Article
Oral Realgar-Indigo Naturalis Formula Treatment for Acute Promyelocytic Leukemia in Children: A Randomized, Control Clinical Trial
Table 1
Baseline characteristics.
| | RIF group (n = 8) | ATO (n = 11) | t-value | -value |
| Sex (n) | Male | 3 | 7 | | 0.375 | Female | 5 | 4 | | | Median age (years) | 10.12 ± 3.2 | 7.36 ± 3.6 | −1.693 | 0.100 | Age group (n) | <5 years | 1 | 2 | | | 5–12 years | 6 | 8 | | | ≥13 years | 1 | 1 | | | Sanz risk (n) | Low–intermediate | 6 | 5 | | 0.310# | High | 2 | 6 | | |
|
|
#Nonparametric test. Fisher’s exact test. RIF: realgar-indigo naturalis formula; ATO: arsenic trioxide. |